HOUSTON, April 24, 2019 /PRNewswire/ -- The Neurology
Center, a medical group practice of top doctors devoted to
excellence in care, located in Houston,
Texas, working in conjunction with two leading neurology and
anti-aging specialists, has made available three-month results of
their randomized controlled investigation of intravenously
administering NuPlasma® young blood plasma into nineteen
Parkinson's disease patients (9 NuPlasma - 10 Placebo).
In a landmark investigation that addresses a well-known
neurological disorder that affects more than 10 million people
worldwide, for which there has been previously no known treatment
that can slow the progression of the disease and available drugs
can only relieve symptoms, the randomized double-blind,
placebo-controlled investigation, designed to evaluate the efficacy
of 25 ml/kg intravenous NuPlasma young Fresh Frozen Plasma (yFFP®)
administered in two doses over three days, continues to realize
dramatic and statistically significant improvements in every
neurological assessment category:
- Complications of Therapy: yFFP improvement 50.0%
- Motor Examination: yFFP improvement 19.2%
- Mentation, Behavior, and Mood: yFFP improvement 12.9%
- Activities of Daily Living: yFFP improvement 7.9%
With all patients continuing to be maintained on their
pre-investigation treatments, critical disease-conditions such as
muscle twitches (dyskinesia), facial expression, speech,
handwriting, rigidity and falling, all show improvement directly
attributable to the yFFP.
The initial one-month results, made available in January, were
an encouraging indication of outcomes. After twelve weeks,
this newly collected data takes the investigation past the point of
where the yFFP is still in circulation, yet continues to show a
prolonged residual benefit.
Full and continuing study disease assessment and blood
laboratory data is accessible online at:
www.youngplasmastudy.com.
About NuPlasma - NuPlasma is an accredited Blood Bank operating
under FDA, AABB and CLIA's Good Manufacturing Practice
regulations. Located in San Marcos,
Texas, NuPlasma is the world's first blood bank to collect
young plasma exclusively from volunteer 18 – 25 year old
donors. NuPlasma is dedicated to Making Lives Better® by
providing physicians with exceptional quality, selection and
service.
*The use of blood and blood products such as plasma in
the United States is restricted
only to the issuance of a prescription by a licensed physician.
CONTACT: Young Plasma Study
PHONE: 512 749-4804
EMAIL: youngplasmastudy@gmail.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/young-blood-plasma-parkinsons-disease-investigation-three-month-results-show-dramatic-improvements-in-every-neurological-assessment-category-300837311.html
SOURCE The Neurology Center